论文部分内容阅读
脾切除治疗再生障碍性贫血(简称再障)已有70余年历史,但国内脾切除治疗小儿再障至今未见报道。我院于1978~1983年5年内共作8例,获得一定效果,今总结临床资料报告如下。一、一般资料:8例中男性7例,女性1例,年龄最小7岁,最大13岁,病程最短2月,最长3年3个月。二、诊断及疗效标准:依据1981年河北省廊坊座谈会纪要附件1及2评定。三、治疗方法:术前均经内科长期多种疗法包括中药、丙酸睾丸素或蛋白同化激素类(如大力补、康力龙、苯丙酸诺龙等)、肾上腺皮质激素、硝酸士的宁、氨肽素、左旋咪唑等,并反复多次输血无效而采用脾切除术。四、随访:凡经脾切除治疗的病儿,出院后每两周来院专科门诊1次,远道者至少每月1次,外省患儿
Splenectomy for aplastic anemia (referred to as aplastic anemia) has more than 70 years of history, but the domestic splenectomy treatment of children with aplasia has not been reported. In our hospital from 1978 to 1983, a total of 8 cases in 5 years to obtain a certain effect, the summary of clinical data are as follows. First, the general information: 8 cases of 7 males and 1 females, the youngest 7 years old, up to 13 years old, the shortest duration in February, up to 3 years and 3 months. Second, the diagnostic and efficacy standards: based on the 1981 Langfang Symposium Annex 1 and 2 assessment. Third, the treatment: preoperative medicine by a variety of long-term, including traditional Chinese medicine, testosterone propionate or protein anabolic hormones (such as Dacoxib, Kang Lilong, nandrolone phenylpropionate, etc.), adrenal cortex hormones, Aminpeptin, levamisole, etc., and repeated multiple transfusions and splenectomy. Fourth, follow-up: All patients treated by splenectomy, discharged from the hospital every two weeks to a specialist clinic, afar, at least once a month, children outside the province